The APP/PSEN1 mouse, a transgenic mouse that overexpresses both the amyloid precursor protein (APP) and presenilin 1 (PSEN1), is a pathological model for amyloid-β plaque formation, a hallmark and a primary pathogenic indicator of Alzheimer’s disease. This evidence concerns the gene PSEN1 and Alzheimer disease.